Williams Jones Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Williams Jones Wealth Management's AZN Position: Q2 2026 in Review
Williams Jones Wealth Management increased its AstraZeneca (AZN) stake by 12% in Q2 2026, buying an estimated $73K and bringing the position to 3,506 shares worth $665K. The position accounts for 0.01% of the portfolio, ranked #334.
Williams Jones Wealth Management first reported a position in AZN in Q1 2022 and has held it in 18 quarters since. 1,505 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Williams Jones Wealth Management held 3,506 shares of AstraZeneca worth $665K as of Q2 2026.
- Williams Jones Wealth Management bought 388 AstraZeneca shares in Q2 2026, an estimated $73K.
- AstraZeneca made up 0.01% of Williams Jones Wealth Management's portfolio in Q2 2026, its #334 holding.
- Williams Jones Wealth Management first reported a position in AstraZeneca in Q1 2022 and has held it in 18 quarters since.
- 1,505 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Williams Jones Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.